ACLA Statement on Release of OSHA and CMS Rules

November 04, 2021 Categories: ACLA News, ACLA Press Releases

Following the Biden Administration’s announcement regarding two new federal rules on COVID-19 vaccination, ACLA President Julie Khani released the following statement: 

“We welcome the Biden Administration’s focus on two key strategies to put the COVID-19 pandemic behind us – vaccination and testing. As we make great strides in broad vaccination uptake, we know that testing must remain a core component of our national response. With a standardized date for implementation, we believe these policies will advance our goal to increase vaccination rates while also providing employers time to establish and implement their testing policies. 

As we approach the January 4, 2022 deadline, clinical laboratories need predictability and continued support in order to respond quickly to the evolving pandemic. ACLA member labs have ample testing capacity and stand ready to meet the nation’s testing needs.”


The American Clinical Laboratory Association (ACLA) is the national trade association representing leading laboratories that deliver essential diagnostic health information to patients and providers. ACLA members are at the forefront of driving diagnostic innovation to meet the country’s evolving health care needs and provide vital clinical laboratory tests that identify and prevent infectious, acute and chronic disease. ACLA works to advance the next generation of health care delivery through policies that expand access to lifesaving testing services.

Print page / Save as PDF